MedPath

Evaluating the Efficacy of Erector Spinae Block in Routine Hip Arthroscopy

Not Applicable
Conditions
Hip Disease
Postoperative Pain
Interventions
Procedure: Erector spinae block
Procedure: Local block
Registration Number
NCT04917510
Lead Sponsor
Carilion Clinic
Brief Summary

The aim of this project is to evaluate the efficacy of preoperative erector spinae blocks in arthroscopic hip surgery. This will be a prospective randomized controlled trial.

Detailed Description

The aim of this project is to evaluate the efficacy of preoperative erector spinae blocks in arthroscopic hip surgery. This will be a prospective randomized controlled trial. The control group will not receive a preoperative block prior to surgery, but will receive local anesthetic at the surgical site at the conclusion of the surgery. The study group will receive a preoperative block and local anesthetic. The primary outcomes will be pain levels and opioid consumption in the post-operative care unit. The secondary outcomes will be pain levels and opioid consumption post-operatively, and functional outcome measures.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
120
Inclusion Criteria
  • All patients undergoing hip arthroscopy for femoroacetabular impingement
  • Ages 13-50
  • Individuals who have the capacity to provide consent or assent for themselves
Exclusion Criteria
  • Hip arthroscopy for any other reason (not undergoing labral repair, acetabuloplasty, and femoral osteochondroplasty)
  • Revision surgery
  • Known narcotic use in the 6 months prior to surgery
  • Workman's compensation patient
  • Pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
StudyErector spinae blockWill receive an erector spinae block prior to surgery using 30-45 mL of 0.25 bupivacaine w/ epinephrine and 5 mL of dexmedetomidine. Will be administered 30 mL of 0.5% marcaine w/ epinephrine as a local block at the surgical site at the conclusion of the procedure.
StudyLocal blockWill receive an erector spinae block prior to surgery using 30-45 mL of 0.25 bupivacaine w/ epinephrine and 5 mL of dexmedetomidine. Will be administered 30 mL of 0.5% marcaine w/ epinephrine as a local block at the surgical site at the conclusion of the procedure.
ControlLocal blockWill not receive erector spinae block. Will be administered 30 mL of 0.5% Marcaine w/ epinephrine as a local block at the surgical site at the conclusion of the procedure.
Primary Outcome Measures
NameTimeMethod
Post Anesthesia Care Unit Pain6 hours post-operatively

Visual analogue pain score at the time of discharge from the Post Anesthesia Care Unit in which 0 equals no pain and 10 equals extreme pain

Post Anesthesia Care Unit Opioids6 hours post-operatively

Total morphine milligram equivalents of administered in the post-operative care unit

Secondary Outcome Measures
NameTimeMethod
Hip disability and Osteoarthritis Outcome Score1 year post-operatively

Hip disability and Osteoarthritis Outcome score at post-op visits in which 0 equals no pain and 100 equals unbearable pain

Patient Reported Outcomes measurement Information System Score1 year post-operatively

Patient Reported Outcomes measurement Information System score at post-op visits in which 0 equals no pain and 10 equals extreme pain

Range Of Motion1 year post-operatively

Hip range of motion in degrees of motion, will be examined by the operative surgeon in the office measured by flexion 0-110 degrees with 0 being no range of motion and 110 being full range of motion, internal rotation -5-25 degrees with -5 being no range of motion and -25 being full range of motion, and external rotation 0-60 degrees with 0 being no range of motion and 60 being full range of motion.

Outpatient Opioids4 weeks post discharge

Opioids consumed after discharge from hospital

Outpatient Visual Analog Scale scores4 weeks post discharge

Pain scores each day for the first 4 weeks after surgery on the Visual Analog Scale in which 0 equals no pain and 10 equals unbearable pain

Trial Locations

Locations (1)

Institute for Orthopedics and Neurosciences

🇺🇸

Roanoke, Virginia, United States

© Copyright 2025. All Rights Reserved by MedPath